🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marco Ventin

Cedars-Sinai Medical Center

ORCID: 0000-0002-4201-7009

Also affiliated with Massachusetts General Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids”.

TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids

Cancer Immunology Research(2025)10.1158/2326-6066.cir-23-1011
N/A
0.530DataRank · unranked
15 citations

Luke Maggs, Apekshya Panda, Samuel J. Wright, Angelina M. Cicerchia, Anne Jenney +23 more

Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0071
N/A
0.515DataRank · unranked
30 citations

Giulia Cattaneo, Shahrzad Arya, Jingyu Jia, Maria Chiara Gelmi, Yi Sun +11 more

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment

Nature Communications(2023)10.1038/s41467-023-41282-x
N/A
0DataRank · unranked
43 citations

David L. Drum, Ruochuan Sun, Yida Zhang, Feng Chen, Fengfei Sun +29 more

B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer

Journal of Experimental & Clinical Cancer Research(2025)10.1186/s13046-025-03475-8
N/A
0DataRank · unranked
4 citations

Marco Ventin, Shahrzad Arya, Cedric Bailey, Venkata R. Vantaku, Jingyu Jia +7 more

Molecular basis for targeting TBK1 in CAR-T cell therapies for cancer

Expert Opinion on Therapeutic Targets(2025)10.1080/14728222.2025.2545845
N/A
0DataRank · unranked
1 citations

Marco Ventin, Luke Maggs, Yi Sun, Cristina R. Ferrone, Russell W. Jenkins +1 more

Neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC) with germline DNA damage repair (DDR) mutations: A dual institution retrospective study.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.4164
N/A
0DataRank · unranked
1 citations

Marco Ventin, Giulia Cattaneo, Arya Shahrzad, Anser Abbas, Brent K. Larson +13 more

Interplay between B7–H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma

Cancer Letters(2024)10.1016/j.canlet.2024.216713
N/A
0DataRank · unranked
6 citations

Marco Ventin, Shahrzad Arya, Filippos Kontos, Theodoros Michelakos, Yurie Sekigami +13 more